TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 68 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $130,000 | +16.1% | 97,364 | -1.5% | 0.00% | – |
Q4 2018 | $112,000 | -79.5% | 98,840 | -50.0% | 0.00% | – |
Q3 2018 | $546,000 | +3.4% | 197,680 | +33.7% | 0.00% | – |
Q2 2018 | $528,000 | +5.6% | 147,835 | -9.3% | 0.00% | – |
Q1 2018 | $500,000 | -32.5% | 162,919 | +38.5% | 0.00% | – |
Q4 2017 | $741,000 | -11.5% | 117,653 | -3.9% | 0.00% | -100.0% |
Q3 2017 | $837,000 | +17.6% | 122,422 | +22.5% | 0.00% | – |
Q2 2017 | $712,000 | -52.1% | 99,919 | -38.2% | 0.00% | -100.0% |
Q1 2017 | $1,486,000 | +189.7% | 161,687 | +27.1% | 0.00% | – |
Q4 2016 | $513,000 | -33.3% | 127,172 | -36.7% | 0.00% | – |
Q3 2016 | $769,000 | -22.5% | 200,780 | -13.0% | 0.00% | -100.0% |
Q2 2016 | $992,000 | +18.2% | 230,758 | +27.4% | 0.00% | 0.0% |
Q1 2016 | $839,000 | -53.8% | 181,136 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $1,817,000 | +33.7% | 181,136 | -0.6% | 0.00% | 0.0% |
Q3 2015 | $1,359,000 | -81.8% | 182,196 | +15.9% | 0.00% | -80.0% |
Q2 2015 | $7,454,000 | +93.5% | 157,135 | +49.4% | 0.01% | +66.7% |
Q1 2015 | $3,853,000 | +0.2% | 105,145 | +8.6% | 0.00% | 0.0% |
Q4 2014 | $3,845,000 | +142.1% | 96,820 | +21.7% | 0.00% | +200.0% |
Q3 2014 | $1,588,000 | +40.9% | 79,579 | -4.7% | 0.00% | 0.0% |
Q2 2014 | $1,127,000 | +127.2% | 83,523 | +83.5% | 0.00% | – |
Q1 2014 | $496,000 | -19.3% | 45,519 | 0.0% | 0.00% | – |
Q4 2013 | $615,000 | +18.7% | 45,519 | 0.0% | 0.00% | – |
Q3 2013 | $518,000 | +65.5% | 45,519 | +2.3% | 0.00% | – |
Q2 2013 | $313,000 | – | 44,486 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |